NCT02965261View on ClinicalTrials.gov

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Fluoxetine Tablet Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Healthy Subjects
Interventions
DRUG

Torrent's Fluoxetine Tablets

DRUG

Warner Chilcott LLC Sarafem Tablets

All Listed Sponsors
lead

Torrent Pharmaceuticals Limited

INDUSTRY

NCT02965261 - Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Fluoxetine Tablet Under Fasting Conditions | Biotech Hunter | Biotech Hunter